Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | E2F5 |
| Upstream (Parents) |
|---|
| (<<) ATIC → E2F5 |
| (<<) BZW2 → E2F5 |
| (<<) CCNB1 → E2F5 |
| (<<) CYP4F2 → E2F5 |
| (<<) DDX21 → E2F5 |
| (<<) FZD4 → E2F5 |
| (<<) KIAA0020 → E2F5 |
| (<<) NR3C1 → E2F5 |
| (<<) PABPC3 → E2F5 |
| (<<) PNO1 → E2F5 |
| (<<) TCF7L1 → E2F5 |
| (<<) TEX10 → E2F5 |
| Downstream (Children) |
|---|
| E2F5 → CASP5 (>>) |
| E2F5 → CBFA2T3 (>>) |
| E2F5 → CXADR (>>) |
| E2F5 → E2F6 (>>) |
| E2F5 → EIF2C2 (>>) |
| E2F5 → FNBP1 (>>) |
| E2F5 → FZD6 (>>) |
| E2F5 → HIST3H3 (>>) |
| E2F5 → HMGCR (>>) |
| E2F5 → HSPA8 (>>) |
| E2F5 → KREMEN2 (>>) |
| E2F5 → LRP8 (>>) |
| E2F5 → MERTK (>>) |
| E2F5 → PFDN2 (>>) |
| E2F5 → PLCG2 (>>) |
| E2F5 → POP1 (>>) |
| E2F5 → PPP1CA (>>) |
| E2F5 → PRR7 (>>) |
| E2F5 → ROR2 (>>) |
| E2F5 → RRP9 (>>) |
| E2F5 → SLC25A32 (>>) |
| E2F5 → SQLE (>>) |
| E2F5 → TRIB3 (>>) |
| E2F5 → YWHAZ (>>) |
